Cargando…

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies

BACKGROUND: There is no clear consensus regarding the safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC) and pre-existing interstitial lung disease (ILD). We aimed to elucidate the impact of ICIs on pre-existing ILD. METHODS: We sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Kinnosuke, Shiroyama, Takayuki, Kuge, Tomoki, Miyake, Kotaro, Yamamoto, Yuji, Yoneda, Midori, Yamamoto, Makoto, Naito, Yujiro, Suga, Yasuhiko, Fukushima, Kiyoharu, Koyama, Shohei, Iwahori, Kota, Hirata, Haruhiko, Nagatomo, Izumi, Takeda, Yoshito, Kumanogoh, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554685/ https://www.ncbi.nlm.nih.gov/pubmed/36248332 http://dx.doi.org/10.21037/tlcr-22-162

Ejemplares similares

Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema
por: Yamamoto, Yuji, et al.
Publicado: (2022)

A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity
por: Nakagawa, Yuta, et al.
Publicado: (2022)

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
por: Tone, Mari, et al.
Publicado: (2023)

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
por: Iwahori, Kota, et al.
Publicado: (2022)

Combined small cell lung carcinoma harboring ALK rearrangement: A case report and literature review
por: Niitsu, Takayuki, et al.
Publicado: (2020)

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination
por: Amiya, Saori, et al.
Publicado: (2022)

Impact of sarcopenia in patients with advanced non–small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study
por: Shiroyama, Takayuki, et al.
Publicado: (2019)

Secondary subcutaneous abscess due to mixed infections by Peptoniphilus olsenii and Gleimia europaea after COVID‐19
por: Yamamoto, Yuji, et al.
Publicado: (2023)

COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
por: Enomoto, Takatoshi, et al.
Publicado: (2022)

Lateral Decubitus Position Enables Further Advancement of the Bronchoscope into the Lung Periphery
por: Miyake, Kotaro, et al.
Publicado: (2022)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer
por: Noda, Yoshimi, et al.
Publicado: (2022)

A lung abscess caused by secondary syphilis – the utility of polymerase chain reaction techniques in transbronchial biopsy: a case report
por: Futami, Shinji, et al.
Publicado: (2019)

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
por: Futami, Yu, et al.
Publicado: (2022)

Pulmonary metastases of lung adenocarcinoma mimicking COVID-19 pneumonia
por: Shiroyama, Takayuki, et al.
Publicado: (2020)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
por: Osa, Akio, et al.
Publicado: (2019)

Fatal cytomegalovirus pneumonia in a critically ill patient with COVID‐19
por: Amiya, Saori, et al.
Publicado: (2021)

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report
por: Naito, Maiko, et al.
Publicado: (2023)

Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres
por: Koba, Taro, et al.
Publicado: (2021)

COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation
por: Noda, Yoshimi, et al.
Publicado: (2021)

Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan
por: Takata, So, et al.
Publicado: (2022)

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients
por: Osa, Akio, et al.
Publicado: (2018)

Tumor-derived semaphorin 4A improves PD-1–blocking antibody efficacy by enhancing CD8(+) T cell cytotoxicity and proliferation
por: Naito, Yujiro, et al.
Publicado: (2023)

Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports
por: Koba, Taro, et al.
Publicado: (2017)

Revisiting Cell Death Responses in Fibrotic Lung Disease: Crosstalk between Structured and Non-Structured Cells
por: Fukushima, Kiyoharu, et al.
Publicado: (2020)

Semaphorin 6D–expressing mesenchymal cells regulate IL-10 production by ILC2s in the lung
por: Naito, Maiko, et al.
Publicado: (2022)

Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment
por: Koyama, Shohei, et al.
Publicado: (2018)

Advances and Challenges of Antibody Therapeutics for Severe Bronchial Asthma
por: Abe, Yuko, et al.
Publicado: (2021)

Bronchoalveolar lavage fluid reveals factors contributing to the efficacy of PD-1 blockade in lung cancer
por: Masuhiro, Kentaro, et al.
Publicado: (2022)

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
por: Otsuka, Tomoyuki, et al.
Publicado: (2022)

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis
por: Minami, Toshiyuki, et al.
Publicado: (2013)

Proposal of a novel pipeline involving precise bronchoscopy of distal peripheral pulmonary lesions for genetic testing
por: Takata, So, et al.
Publicado: (2022)

Development of microscopic polyangiitis-related pulmonary fibrosis in a patient with autoimmune pulmonary alveolar proteinosis
por: Kinehara, Yuhei, et al.
Publicado: (2014)

Impact of Lymphopenia Recovery After Chemoradiotherapy on Durvalumab Consolidation Therapy in Stage III NSCLC
por: Kuge, Tomoki, et al.
Publicado: (2023)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
por: Kinehara, Yuhei, et al.
Publicado: (2023)

Evaluation of disease severity in bronchiectasis using impulse oscillometry
por: Yamamoto, Yuji, et al.
Publicado: (2020)

Identifying phenotypes in interstitial lung disease using group-based trajectory modelling
por: Takata, S., et al.
Publicado: (2023)

Double deletion of tetraspanins CD9 and CD81 in mice leads to a syndrome resembling accelerated aging
por: Jin, Yingji, et al.
Publicado: (2018)

The impact of CCR8+ regulatory T cells on cytotoxic T cell function in human lung cancer
por: Haruna, Miya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl57c63tmgalo0cvbci4mjrj5u